FIELD: medicine.
SUBSTANCE: presented inventions relate to use of an agent stimulating tissue regeneration, and a method of stimulating repair of mesenchymal or epithelial neurological tissues by administering said agent. Described agent is an S100A8 protein, a cell which secretes an S100A8 protein, a vector into which DNA encoding S100A8 protein is inserted, an S100A9 protein, a cell which secretes an S100A9 protein or a vector into which DNA encoding an S100A8-9 protein is inserted.
EFFECT: presented inventions can be used for inducing healing of injured tissues by recruiting bone-marrow-derived cells in area of damage, thereby treating such diseases as extensive pitting skin, bone fractures, cerebral infarction.
7 cl, 44 dwg, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR HIGH-EFFICIENCY COLLECTION OF FUNCTIONAL CELLS IN VIVO | 2009 |
|
RU2571230C2 |
| PREPARATION FOR INVOLVING ORIGINATING FROM BONE MARROW PLURIPOTENT STEM CELL INTO PERIPHERAL BLOOD FLOW | 2009 |
|
RU2519714C2 |
| NEW METHOD OF TREATMENT OF MYOCARDIAL INFARCTION WITH APPLICATION OF FRAGMENT HMGB1 | 2013 |
|
RU2647467C2 |
| NOVEL METHOD FOR TREATING SPINAL CORD INJURY USING HMGB1 FRAGMENT | 2013 |
|
RU2649069C2 |
| STEM CELL MATERIAL AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2785588C2 |
| ENGINEERED MESENCHYMAL STEM CELLS AND METHOD FOR USING THEM FOR TREATING TUMOURS | 2010 |
|
RU2539099C2 |
| IMMORTALIZED STEM CELLS AND DRUG COMPOSITION AND DRUG PREPARATION CONTAINING IT AS AN ACTIVE INGREDIENT | 2013 |
|
RU2619221C2 |
| THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
| STEM CELL MATERIAL AND METHOD FOR ITS RECEPTION | 2014 |
|
RU2644650C2 |
| METHOD OF CULTIVATION PLURIPOTENTIAL STEM CELLS | 2005 |
|
RU2375448C2 |
